Novel method for the determination of solubility in aerosol propellants

Abhishek Gupta, Paul B. Myrdal

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


A new on-line reverse-phase high-performance liquid chromatography method to determine the solubility of compounds in propellant-based metered-dose inhaler (MDI) formulations was developed. The new method uses a direct injection from an MDI vial into the port of a manual injector. The MDI vials were coupled with a filtration and injection assembly to filter the excess compound, and deliver the filtrate of the MDI vials to the injector port of the manual injector. A backpressure regulator was connected to the manual injector, to maintain the propellant in the liquid state after injection from the MDI vial. Phase separation studies were conducted to investigate the miscibility of hydrofluoroalkane 134a with different mobile-phase solvent compositions. Characterization of the new direct injection method was done by evaluating sample presentation and chromatography variables to determine the robust nature of the method. Beclomethasone dipropionate in ethanol/hydrofluoroalkane 134a was used as a model system for development. A chemically diverse set of nine compounds was used to evaluate solubility measurement reproducibility. Solubilities were determined at two different temperatures (25 and 37°C) and the average relative standard deviation for all of the solubility measurements was <4%.

Original languageEnglish (US)
Pages (from-to)2411-2419
Number of pages9
JournalJournal of pharmaceutical sciences
Issue number10
StatePublished - Oct 2004


  • Aerosol
  • HFA 134a
  • HPLC (high-performance/pressure liquid chromatography)
  • Metered-dose inhaler
  • Pulmonary drug delivery
  • Solubility

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Novel method for the determination of solubility in aerosol propellants'. Together they form a unique fingerprint.

Cite this